Peptilogics Receives Qualified Infectious Disease Product Designation from FDA for Lead Compound PLG0206 as a Treatment for Prosthetic Joint Infection by Morgane De Pol | Jun 7, 2018
Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration by mcwebmaster | Dec 19, 2017
